This presentation by Dr. Avinash Jain on Rheuma TV explores the role of Iguratimod (IGU) in modern rheumatology, focusing on the evolution of Rheumatoid Arthritis (RA) therapies and the clinical positioning of novel/synthetic DMARDs. The talk provides a comprehensive overview of Iguratimod’s mechanism of action, therapeutic efficacy, safety profile, contraindications, and strategies for monitoring and managing potential side effects in clinical practice.
